Using lithium as a neuroprotective agent in patients with cancer
Version 3 2024-06-20, 01:19Version 3 2024-06-20, 01:19
Version 2 2024-05-30, 15:36Version 2 2024-05-30, 15:36
Version 1 2014-10-28, 09:57Version 1 2014-10-28, 09:57
journal contribution
posted on 2024-06-20, 01:19 authored by M Khasraw, D Ashley, G Wheeler, Michael BerkMichael BerkUsing lithium as a neuroprotective agent in patients with cancer
History
Journal
BMC MedicineVolume
10Article number
ARTN 131Pagination
1 - 7Location
EnglandPublisher DOI
Open access
- Yes
ISSN
1741-7015eISSN
1741-7015Language
EnglishNotes
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Publication classification
C1 Refereed article in a scholarly journalCopyright notice
2012, Khasraw et al.Issue
1Publisher
BMCPublication URL
Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineGLUTAMATE-RECEPTOR SUPERSENSITIVITYHIPPOCAMPAL NEUROGENESISBREAST-CANCERRADIATION-THERAPYSTEM-CELLCOGNITIVE FUNCTIONSYNTHASE KINASE-3BRAINIRRADIATIONSURVIVORS110999 Neurosciences not elsewhere classified970111 Expanding Knowledge in the Medical and Health Sciences
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC